Product Category

Buclizine

  • Product Name : Buclizine
  • Grade : IP / BP / USP
  • Therapeutic Category : Antiemetic
  • CAS No : 129-74-8
  • COA : Available
  • MSDS : Available
Request A Quote

Description

Buclizine is an antihistamine and anticholinergic of the piperazine derivative family. It is considered to be an antiemetic, similar to meclizine.

Properties STANDARD
Condition of water solution Passes test
Cd≤% 0.0001
Lead(Pb)%max 0.001
Arsenic(As)%max 0.0001
Hg≤% 0.0001
PH 3.2-3.8
Loss on drying %max 0.5
Specific Rotation +17.5 ~ +18.5
Melting Point 110-120°C
E. Coli Negative
Salmonelia Negative
Coliforms Negative
Yeast &Mould <100g
Total plate count ≤3000g
Appearance White crystalline powder

 Packaging details:

 

Packaging details: 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Storage: Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat
Shelf Life: 5 years if sealed and store away from direct sun light.

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

ASIA: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Australia, New Zealand, Fiji, and so forth.